Emtriva and Mobility decreased - a phase IV clinical study of FDA data

Summary:

Mobility decreased is reported as a side effect among people who take Emtriva (emtricitabine), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Truvada, and have Hiv infection.

The phase IV clinical study analyzes which people have Mobility decreased when taking Emtriva. It is created by eHealthMe based on reports of 2,376 people who have side effects when taking Emtriva from the FDA, and is updated regularly.

What is Emtriva?

Emtriva has active ingredients of emtricitabine. eHealthMe is studying from 2,383 Emtriva users. Check the latest studies of Emtriva.

What is Mobility decreased?

Mobility decreased (ability to move is reduced) is found to be associated with 1,776 drugs and 1,635 conditions by eHealthMe. Check the latest studies of Mobility decreased.

On Jul, 31, 2026

2,376 people reported to have side effects when taking Emtriva.
Among them, 45 people (1.89%) have Mobility decreased.

Among these 45 people:

How long have people been on Emtriva when they have Mobility decreased? *

What is the gender of people who have Mobility decreased when taking Emtriva? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Mobility decreased when taking Emtriva? *

What are other drugs people take besides Emtriva? *

What are other side effects people have besides Mobility decreased? *

Pain: 41 people, 91.11%
Emotional Distress: 41 people, 91.11%
Stress And Anxiety: 35 people, 77.78%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 31 people, 68.89%
Chronic Kidney Disease: 25 people, 55.56%
Bone Density Decreased: 21 people, 46.67%
Osteoporosis (bones weak and more likely to break): 20 people, 44.44%
Osteopenia (a condition where bone mineral density is lower than normal): 17 people, 37.78%
Acute Kidney Failure: 13 people, 28.89%
Fatigue (feeling of tiredness): 12 people, 26.67%

What are the existing conditions these people have? *

Hiv Infection: 45 people, 100.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 11.11%
Hypersensitivity: 5 people, 11.11%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 11.11%
Diabetes: 4 people, 8.89%
High Blood Pressure: 4 people, 8.89%
Depression: 4 people, 8.89%
Affective Disorder (mental disorder): 3 people, 6.67%
Pain: 3 people, 6.67%
High Blood Cholesterol: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Emtriva and have Mobility decreased?

- Check whether Mobility decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emtriva:

Emtriva (2,383 reports)

Browse all side effects of Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mobility decreased:

Mobility decreased (1,776 drugs)

Browse all the conditions that are associated with Mobility decreased:

Mobility decreased (1,635 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on emtricitabine (the active ingredients of Emtriva) and Emtriva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.